However, it should be noted that AML in general has a worse prognosis than B-ALL, and hence the actual prognosis appears to be similar between MLL-r AML and MLL-r B-ALL [3, 6, 8, 30]. This evidence concerns the gene KMT2A and acute myeloid leukemia.